Canada - English - Health Canada

novartis pharmaceuticals canada inc - timolol (timolol maleate); brinzolamide - suspension - 0.5%; 1% - timolol (timolol maleate) 0.5%; brinzolamide 1% - beta-adrenergic agents

United Kingdom - English - myHealthbox

teva uk limited, eastbourne - brinzolamide - eye drops, suspension - 10mg/ml - antiglaucoma preparations and miotics, carbonic anhydrase inhibitors - it is indicated to decrease elevated intraocular pressure in: • ocular hypertension • open-angle glaucoma as monotherapy in adult patients unresponsive to beta-blockers or in adult patients in whom beta-blockers are contraindicated, or as adjunctive therapy to beta-blockers or prostaglandin analogues

United Kingdom - English - myHealthbox

pharmathen s.a - brinzolamide - eye drops, suspension - 10mg/ml - antiglaucoma preparations and miotics, carbonic anhydrase inhibitors - it is indicated to decrease elevated intraocular pressure in: • ocular hypertension • open-angle glaucoma as monotherapy in adult patients unresponsive to beta-blockers or in adult patients in whom beta-blockers are contraindicated, or as adjunctive therapy to beta-blockers or prostaglandin analogues

Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

lusomedicamenta sociedade tecnica farmaceutica - brinzolamide - drops eye (suspension) - 10mg/ml

United Kingdom - English - myHealthbox

wockhardt uk ltd - brinzolamide - eye drops, suspension - 10mg/ml - antiglaucoma preparations and miotics, carbonic anhydrase inhibitors - it is indicated to decrease elevated intraocular pressure in: • ocular hypertension • open-angle glaucoma as monotherapy in adult patients unresponsive to beta-blockers or in adult patients in whom beta-blockers are contraindicated, or as adjunctive therapy to beta-blockers or prostaglandin analogues

United Kingdom - English - myHealthbox

generics [uk] limited t/a mylan - brinzolamide - eye drops, suspension - 10mg/ml - antiglaucoma preparations and miotics, carbonic anhydrase inhibitors - it is indicated to decrease elevated intraocular pressure in: • ocular hypertension • open-angle glaucoma as monotherapy in adult patients unresponsive to beta-blockers or in adult patients in whom beta-blockers are contraindicated, or as adjunctive therapy to beta-blockers or prostaglandin analogues

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

accord-uk ltd - brinzolamide - eye drops - 10mg/1ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

viatris uk healthcare ltd - brinzolamide - eye drops - 10mg/1ml

Israel - English - Ministry of Health

novartis israel ltd - brinzolamide - ophthalmic suspension - brinzolamide 1 % - brinzolamide - brinzolamide - alcon azopt is indicated to decrease elevated intraocular pressure in: ocular hypertension open-angle glaucoma as monotherapy in patients unresponsive to beta-blockers or in patients in whom beta-blockers are contra-indicated or as adjunctive therapy to beta-blockers.

New Zealand - English - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - brinzolamide 10 mg/ml (a 2% overage is applied during manufacture);  ; timolol maleate 6.8 mg/ml equivalent to 5 mg/ml (0.5%) timolol as free base;   - eye drops, suspension - 1%/0.5% - active: brinzolamide 10 mg/ml (a 2% overage is applied during manufacture)   timolol maleate 6.8 mg/ml equivalent to 5 mg/ml (0.5%) timolol as free base   excipient: benzalkonium chloride carbomer disodium edetate hydrochloric acid mannitol purified water sodium chloride sodium hydroxide tyloxapol - azarga is indicated for the decrease of intraocular pressure (iop) in patients with open-angle glaucoma or ocular hypertension for whom monotherapy with either component provides insufficient iop reduction